PDE3A Gene: Structure, Function, and Clinical Significance

A comprehensive overview of the PDE3A gene, its protein product, associated diseases, and expression patterns.

Gene Information Card

Symbol PDE3A
Full Name phosphodiesterase 3A
Gene Type protein-coding
Chromosomal Location 12p12.2
NCBI Gene ID 5139 ncbi.nlm.nih.gov/gene/5139
Ensembl ID ENSG00000172572
UniProt ID Q14432
OMIM ID 123805
HGNC ID 8778
Aliases CGI-PDE, HcGIP, cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A

Description

The PDE3A gene encodes phosphodiesterase 3A, an enzyme that hydrolyzes cyclic AMP (cAMP) and cyclic GMP (cGMP), playing a critical role in cellular signaling. It is involved in various physiological processes including cardiac contractility, smooth muscle relaxation, and platelet aggregation. Mutations and altered expression of PDE3A have been linked to hypertension and other cardiovascular conditions.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hypertension Gain-of-function mutations in PDE3A increase cAMP hydrolysis, leading to altered vascular tone and elevated blood pressure. ClinVar, OMIM
Brachydactyly with hypertension Specific missense mutations in PDE3A cause constitutive activation, resulting in skeletal and vascular abnormalities. OMIM, PubMed
Cardiovascular disease PDE3A expression changes contribute to heart failure and atherosclerosis through modulation of cAMP signaling. NCBI Gene, PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Heart High High
Skeletal Muscle Medium Medium
Brain Medium Medium
Liver Low Low
Kidney Medium Medium
Cell Line Expression
Cell Line nTPM Notes
HEK293 Medium Commonly used for functional studies
HeLa Low Low endogenous expression
A549 Medium Lung carcinoma cell line
HUVEC High Endothelial cells, relevant to vascular function
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1334A>G (p.Tyr445Cys) Missense Rare Gain-of-function, associated with hypertension
c.2116C>T (p.Arg706Trp) Missense Rare Gain-of-function, linked to brachydactyly with hypertension
c.1000G>A (p.Glu334Lys) Missense Not reported Potential functional impact, not clinically validated
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations are rare and may lead to reduced cAMP hydrolysis, potentially affecting cardiac contractility, but no specific disease association has been established.

Gain of Function (GOF)

Gain-of-function mutations increase PDE3A activity, leading to decreased cAMP levels, which is associated with hypertension and brachydactyly with hypertension.

Dominant Negative (DN)

No dominant-negative mutations have been reported for PDE3A.

Gene Ontology (GO)

• 3' • 5'-cyclic-nucleotide phosphodiesterase activity
• cAMP binding • cGMP binding
• metal ion binding • signal transduction

Pathways

• cAMP signaling pathway
• cGMP-PKG signaling pathway
• Purine metabolism

Protein Summary

PDE3A is a 125 kDa protein that belongs to the cyclic nucleotide phosphodiesterase family. It contains a catalytic domain that hydrolyzes cAMP and cGMP, with higher affinity for cAMP. The protein is anchored to the membrane via N-terminal hydrophobic regions and is regulated by phosphorylation and interaction with other proteins. PDE3A is a target for drugs like cilostazol and milrinone, used in cardiovascular diseases.

Related Products

Product name Cat.No. Species Gene ID
PDE3A Knockout HEK293 Cell Line EDJ-KQ1827 Human 5139 Details Get a Quote
PDE3A Knockout A-549 Cell Line EDJ-KQ21678 Human 5139 Details Get a Quote
PDE3A Knockout HeLa Cell Line EDJ-KQ21679 Human 5139 Details Get a Quote
PDE3A Knockout HCT 116 Cell Line EDJ-KQ71059 Human 5139 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
How did you hear about us: